BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12471707)

  • 1. Dose-dependent anhidrotic effect of botulinum toxin.
    Erbguth FJ
    Curr Probl Dermatol; 2002; 30():131-40. PubMed ID: 12471707
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up.
    Birklein F; Eisenbarth G; Erbguth F; Winterholler M
    J Invest Dermatol; 2003 Dec; 121(6):1312-6. PubMed ID: 14675175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anhidrotic effect of intradermal injections of botulinum toxin: a comparison of different products and concentrations.
    Rystedt A; Swartling C; Naver H
    Acta Derm Venereol; 2008; 88(3):229-33. PubMed ID: 18480920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
    Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
    Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: measured by sudometry.
    Braune C; Erbguth F; Birklein F
    Br J Dermatol; 2001 Jan; 144(1):111-7. PubMed ID: 11167691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin and sweating.
    Bushara KO; Park DM
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57(11):1437-8. PubMed ID: 7964832
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study.
    Hecht MJ; Birklein F; Winterholler M
    Arch Dermatol Res; 2004 Feb; 295(8-9):318-9. PubMed ID: 14648075
    [No Abstract]   [Full Text] [Related]  

  • 8. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis.
    Rosell K; Hymnelius K; Swartling C
    Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin for treatment of craniofacial hyperhidrosis.
    Böger A; Herath H; Rompel R; Ferbert A
    J Neurol; 2000 Nov; 247(11):857-61. PubMed ID: 11151418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of botulinum toxin type B on residual limb sweating and pain. Is there a chance for indirect phantom pain reduction by improved prosthesis use?].
    Kern KU; Kohl M; Seifert U; Schlereth T
    Schmerz; 2012 Apr; 26(2):176-84. PubMed ID: 22527647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study.
    Saadia D; Voustianiouk A; Wang AK; Kaufmann H
    Neurology; 2001 Dec; 57(11):2095-9. PubMed ID: 11739832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of botulinum toxin concentration on reduction in sweating: a randomized, double-blind study.
    Rystedt A; Karlqvist M; Bertilsson M; Naver H; Swartling C
    Acta Derm Venereol; 2013 Nov; 93(6):674-8. PubMed ID: 23694974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin for palmar hyperhidrosis.
    Naumann M; Flachenecker P; Bröcker EB; Toyka KV; Reiners K
    Lancet; 1997 Jan; 349(9047):252. PubMed ID: 9014916
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of axillary hyperhidrosis].
    Pomarède N
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S125-8. PubMed ID: 19576478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical botulinum toxin to treat hyperhidrosis? No sweat!
    Lim EC; Seet RC; Chow A; Oh VM; Ong BK; Wilder-Smith EP
    Med Hypotheses; 2006; 67(1):27-32. PubMed ID: 16524669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect and persistency of botulinum toxin iontophoresis in the treatment of palmar hyperhidrosis.
    Davarian S; Kalantari KK; Rezasoltani A; Rahimi A
    Australas J Dermatol; 2008 May; 49(2):75-9. PubMed ID: 18412805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
    Karamfilov T; Konrad H; Karte K; Wollina U
    Arch Dermatol; 2000 Apr; 136(4):487-90. PubMed ID: 10768647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Axillary hyperhidrosis: successful treatment with botulinum toxin A].
    Heckmann M; Breit S; Ceballos-Baumann A; Schaller M; Plewig G
    Hautarzt; 1998 Feb; 49(2):101-3. PubMed ID: 9551330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of objective methods to diagnose palmar hyperhidrosis and monitor effects of botulinum toxin treatment.
    Krogstad AL; Skymne BS; Göran Pegenius BS; Elam M; Wallin BG
    Clin Neurophysiol; 2004 Aug; 115(8):1909-16. PubMed ID: 15261869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.